Glenmark Life Sciences IPO vs Tatva Chintan Pharma IPO

Comparision between Glenmark Life Sciences IPO and Tatva Chintan Pharma IPO.

IPO Details

Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tatva Chintan Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Glenmark Life Sciences IPO	Tatva Chintan Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Bofa Securities India Limited Bob Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Goldman Sachs (India) Securities Private Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited	ICICI Securities Limited Jm Financial Limited
Registrar	Kfin Technologies Limited	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Tatva Chintan Pharma IPO is up to ₹500.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Tatva Chintan Pharma IPO is ₹1,083.00 per share.

	Glenmark Life Sciences IPO	Tatva Chintan Pharma IPO
Face Value	₹2 per share	₹10 per share
Issue Price (Lower)	₹695.00 per share	₹1,073.00 per share
Issue Price (Upper)	₹720.00 per share	₹1,083.00 per share
Issue Price (Final)	₹720.00 per share	₹1,083.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	20 shares	13 shares
Fresh Issue Size
Fresh Issue Size (Amount)	up to ₹1,060.00 Cr	up to ₹225.00 Cr
OFS Issue Size	63,00,000 shares
OFS Issue Size (Amount)	up to ₹453.60 Cr	up to ₹275.00 Cr
Issue Size Total
Issue Size Total (Amount)	up to ₹1,513.60 Cr	up to ₹500.00 Cr

IPO Timetable

Glenmark Life Sciences IPO opens on Jul 27, 2021, while Tatva Chintan Pharma IPO opens on Jul 16, 2021. The closing date of Glenmark Life Sciences IPO and Tatva Chintan Pharma IPO is Jul 29, 2021, and Jul 20, 2021, respectively.

	Glenmark Life Sciences IPO	Tatva Chintan Pharma IPO
Anchor Bid Date
Issue Open	Jul 27, 2021	Jul 16, 2021
Issue Close	Jul 29, 2021	Jul 20, 2021
Basis Of Allotment (Tentative)	Aug 03, 2021	Jul 26, 2021
Initiation of Refunds (Tentative)	Aug 04, 2021	Jul 27, 2021
Credit of Share (Tentative)	Aug 05, 2021	Jul 28, 2021
Listing date (Tentative)	Aug 06, 2021	Jul 29, 2021
Anchor Lockin End date 1	Sep 02, 2021	Aug 25, 2021
Anchor Lockin End date 2	Nov 01, 2021	Oct 24, 2021

Financials

Glenmark Life Sciences IPO P/E ratio is , as compared to Tatva Chintan Pharma IPO P/E ratio of .

Glenmark Life Sciences IPO

Tatva Chintan Pharma IPO

Financial

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	19,970.75	17,256.04	14,753.95
Total Revenue	18,859.76	15,493.03	8,868.65
Profit After Tax	3,515.81	3,130.98	1,955.92

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	3,148.03	2,489.38	1,875.08
Total Revenue	3,062.92	2,646.22	2,068.01
Profit After Tax	522.62	377.89	205.43

Promoter Shareholding (Pre-Issue)

100%

Promoter Shareholding (Post-Issue)

82.84%

79.17%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in Tatva Chintan Pharma IPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 9,31,966 shares in Tatva Chintan Pharma IPO.

	Glenmark Life Sciences IPO	Tatva Chintan Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB	42,42,379 shares	9,31,966 shares
NII	32,32,770 shares	6,98,975 shares
RII	75,43,130 shares	16,30,941 shares
Employee	0 shares	0 shares
Others
Total	1,50,18,279 shares	32,61,882 shares

Bids Received (Subscription)

Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Tatva Chintan Pharma IPO subscribed 180.36x.

	Glenmark Life Sciences IPO	Tatva Chintan Pharma IPO
QIB (times)	36.97x	185.23x
NII (times)	122.54x	512.22x
Big NII (times)
Small NII (times)
RII (times)	14.63x	35.35x
Employee (times)
Other (times)
Total (times)	44.17x	180.36x

Compare with others

Glenmark Life Sciences IPO	Tatva Chintan Pharma IPO
Nuvoco IPO	Windlas Biotech IPO
Rolex Rings IPO	Exxaro Tiles IPO
Paytm IPO	Nuvoco IPO
Tatva Chintan Pharma IPO	Rolex Rings IPO
Zomato IPO	Paytm IPO
Clean Science IPO	Zomato IPO
G R Infraprojects IPO	Glenmark Life Sciences IPO
India Pesticides IPO	Clean Science IPO
Ruchi Soya FPO	G R Infraprojects IPO
KIMS IPO	India Pesticides IPO

Comments

Add a public comment...